neurotensin [Ligand Id: 1579] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL407196 (Neurotensin)
  • NTS1 receptor/Neurotensin receptor 1 in Human [ChEMBL: CHEMBL4123] [GtoPdb: 309] [UniProtKB: P30989]
  • NTS1 receptor/Neurotensin receptor 1 in Mouse [ChEMBL: CHEMBL3570] [GtoPdb: 309] [UniProtKB: O88319]
  • NTS1 receptor/Neurotensin receptor 1 in Rat [ChEMBL: CHEMBL3027] [GtoPdb: 309] [UniProtKB: P20789]
There should be some charts here, you may need to enable JavaScript!
  • NTS2 receptor/Neurotensin receptor 2 in Human [ChEMBL: CHEMBL2514] [GtoPdb: 310] [UniProtKB: O95665]
  • NTS2 receptor in Mouse [GtoPdb: 310] [UniProtKB: P70310]
  • NTS2 receptor/Neurotensin receptor 2 in Rat [ChEMBL: CHEMBL5106] [GtoPdb: 310] [UniProtKB: Q63384]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
NTS1 receptor/Neurotensin receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4123] [GtoPdb: 309] [UniProtKB: P30989]
ChEMBL Displacement of [3H]neurotensin from human NTS1 receptor expressed in CHO cells B 9.23 pKd 0.59 nM Kd J Med Chem (2011) 54: 2915-2923 [PMID:21446649]
ChEMBL Displacement of [3H]neurotensin from human NTS1 receptor expressed in CHO cells B 9.29 pKd 0.51 nM Kd J Med Chem (2013) 56: 9361-9365 [PMID:24160350]
ChEMBL Displacement of [125I]Tyr3-neurotensin from human recombinant NTS1 stably expressed in CHO-K1 cell membranes incubated for 60 mins by gamma counter analysis B 8.48 pKi 3.3 nM Ki J Med Chem (2021) 64: 2110-2124 [PMID:33538583]
ChEMBL Displacement of [3H]NT(8-13) from wild type human NTR1 expressed in HEK293 cells B 8.68 pKi 2.1 nM Ki Bioorg Med Chem (2008) 16: 9359-9368 [PMID:18809332]
ChEMBL Displacement of [125I]I-Tyr(3)NT from human NTR1 B 8.79 pKi 1.64 nM Ki J Med Chem (2009) 52: 1803-1813 [PMID:19290594]
ChEMBL Displacement of radiolabeled neurotensin from human neurotensin receptor 1 B 8.82 pKi 1.5 nM Ki J Med Chem (2008) 51: 7094-7098 [PMID:18983139]
ChEMBL Binding affinity to human neurotensin receptor 1 B 8.92 pKi 1.2 nM Ki ACS Med Chem Lett (2020) 11: 16-22 [PMID:31938457]
ChEMBL Binding affinity to human NTS1 receptor by radioligand displacement assay B 9.57 pKi 0.27 nM Ki Eur J Med Chem (2013) 63: 85-94 [PMID:23466604]
GtoPdb - - 9.7 pKi - - - Mol Pharmacol (2001) 60: 1392-8 [PMID:11723247];
Biochem Pharmacol (2000) 60: 793-801 [PMID:10930533]
ChEMBL Antagonist activity at human NTS1 receptor expressed in CHOK1 cells assessed as inhibition of intracellular calcium elevation pretreated 30 mins before with SR-48692 by FLIPR assay F 8.22 pIC50 6.03 nM IC50 Bioorg Med Chem Lett (2008) 18: 5789-5789 [PMID:18849166]
ChEMBL Displacement of [125I]I-Tyr(3)NT from human NTR1 B 8.66 pIC50 2.19 nM IC50 J Med Chem (2009) 52: 1803-1813 [PMID:19290594]
ChEMBL Displacement of radiolabeled neurotensin from human neurotensin receptor 1 B 8.74 pIC50 1.8 nM IC50 J Med Chem (2008) 51: 7094-7098 [PMID:18983139]
ChEMBL Inhibition of human NTS1 receptor B 8.85 pIC50 1.4 nM IC50 J Med Chem (2008) 51: 4150-4169 [PMID:18588282]
ChEMBL Displacement of [125I]Tyr3-NT from human NTS1R expressed in HT29 cells B 9.21 pIC50 0.62 nM IC50 J Med Chem (2006) 49: 4767-4776 [PMID:16854083]
ChEMBL Displacement of [125I]Tyr3-neurotensin from human recombinant NTS1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method B 9.31 pIC50 0.49 nM IC50 Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250]
ChEMBL Displacement of [125I]Tyr3-neurotensin from human recombinant NT1 receptor expressed in CHO cells B 9.31 pIC50 0.49 nM IC50 Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801]
ChEMBL Displacement of [125I]Tyr3-NT from human NTS1R expressed in WiDr cells B 9.34 pIC50 0.46 nM IC50 J Med Chem (2006) 49: 4767-4776 [PMID:16854083]
ChEMBL Binding affinity to human NTS1 receptor by radioligand displacement assay B 9.48 pIC50 0.33 nM IC50 Eur J Med Chem (2013) 63: 85-94 [PMID:23466604]
ChEMBL Binding affinity to NTS1 receptor (unknown origin) by radioligand displacement assay B 9.62 pIC50 0.24 nM IC50 Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449]
ChEMBL Binding affinity towards neurotensin receptor in membranes prepared from HT-29 cell line, relative to [111In]-labeled neurotensin peptide B 9.7 pIC50 0.2 nM IC50 J Med Chem (2003) 46: 3403-3411 [PMID:12852770]
ChEMBL Agonist activity at human NTS1 receptor expressed in CHOK1 cells assessed as increase in intracellular calcium level by FLIPR assay F 6.51 pEC50 310 nM EC50 Bioorg Med Chem Lett (2008) 18: 5789-5789 [PMID:18849166]
ChEMBL Agonist activity at human NTR1 assessed as increase in intracellular calcium concentration F 8.7 pEC50 2 nM EC50 J Med Chem (2009) 52: 1803-1813 [PMID:19290594]
ChEMBL Agonist activity at NTR1 in human HT-29 cells assessed as increase in intracellular calcium concentration by FLIPR assay F 8.7 pEC50 1.98 nM EC50 J Med Chem (2009) 52: 1803-1813 [PMID:19290594]
ChEMBL Agonist activity at human NTS1 receptor expressed in HEK293 cells assessed as inhibition of constitutive activity on MAPK-mediated luciferase activity F 8.8 pEC50 1.6 nM EC50 J Med Chem (2011) 54: 2915-2923 [PMID:21446649]
ChEMBL Agonist activity at NTR1 expressed in CHOK1 cells by calcium mobilization assay F 9.64 pEC50 0.23 nM EC50 Bioorg Med Chem Lett (2009) 19: 1438-1441 [PMID:19195889]
NTS1 receptor/Neurotensin receptor 1 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3570] [GtoPdb: 309] [UniProtKB: O88319]
ChEMBL Concentration producing half maximal inhibition of specific binding of [125I]-Tyr3-NT(1-13) to NT receptor in neonatal mouse whole brain (minus cerebellum) B 9.77 pKi 0.17 nM Ki Bioorg Med Chem Lett (1993) 3: 949-952
ChEMBL Agonist activity at NTR1 in mouse N1E-115 cells assessed as increase in intracellular calcium concentration F 8.7 pEC50 2 nM EC50 J Med Chem (2009) 52: 1803-1813 [PMID:19290594]
NTS1 receptor/Neurotensin receptor 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3027] [GtoPdb: 309] [UniProtKB: P20789]
ChEMBL Displacement of [125L]NT from rat neurotensin receptor type 1 expressed in CHOK1 cells by radioligand binding assay B 8.77 pKi 1.7 nM Ki Bioorg Med Chem Lett (2015) 25: 292-296 [PMID:25499438]
ChEMBL Displacement of [125I]neurotensin from rat NTS1 receptor expressed in CHO-K1 cells by competitive binding assay B 8.96 pKi 1.1 nM Ki J Med Chem (2014) 57: 7472-7477 [PMID:25157640]
GtoPdb - - 10 pKi - - - Mol Pharmacol (2003) 64: 421-9 [PMID:12869647];
Biochem Pharmacol (2000) 60: 793-801 [PMID:10930533];
J Biol Chem (1998) 273: 16351-7 [PMID:9632698]
ChEMBL Agonist activity at rat NTS1 stably expressed in CHOK1 cells assessed as induction of calcium release by FLIPR assay F 10.4 pEC50 0.04 nM EC50 J Med Chem (2014) 57: 5318-5332 [PMID:24856674]
NTS2 receptor/Neurotensin receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2514] [GtoPdb: 310] [UniProtKB: O95665]
ChEMBL Displacement of [3H]NT from human NTS2 receptor expressed in HEK293 cells B 8.31 pKi 4.9 nM Ki J Med Chem (2011) 54: 2915-2923 [PMID:21446649]
ChEMBL Displacement of [3H]NT(8 to 13) from human NTS2 receptor expressed in HEK293 cells B 8.31 pKi 4.9 nM Ki J Med Chem (2013) 56: 9361-9365 [PMID:24160350]
ChEMBL Displacement of [125I]Tyr3-neurotensin from human recombinant NTS2 stably expressed in human 1321N1 cell membranes incubated for 60 mins by gamma counter analysis B 8.39 pKi 4.1 nM Ki J Med Chem (2021) 64: 2110-2124 [PMID:33538583]
GtoPdb - - 8.8 pKi - - - Mol Pharmacol (2001) 60: 1392-8 [PMID:11723247]
ChEMBL Agonist activity at human NTS2 receptor expressed in HEK293 cells assessed as inhibition of constitutive activity on MAPK-mediated luciferase activity F 6.96 pEC50 110 nM EC50 J Med Chem (2011) 54: 2915-2923 [PMID:21446649]
NTS2 receptor in Mouse [GtoPdb: 310] [UniProtKB: P70310]
GtoPdb - - 8.7 pIC50 - - - Biochem Biophys Res Commun (1998) 243: 585-90 [PMID:9480852]
NTS2 receptor/Neurotensin receptor 2 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5106] [GtoPdb: 310] [UniProtKB: Q63384]
ChEMBL Displacement of [125I]neurotensin from rat NTS2 receptor expressed in CHO-K1 cells by competitive binding assay B 7.55 pKi 28 nM Ki J Med Chem (2014) 57: 7472-7477 [PMID:25157640]
ChEMBL Displacement of [125L]NT from rat neurotensin receptor type 2 expressed in CHOK1 cells by radioligand binding assay B 7.68 pKi 21 nM Ki Bioorg Med Chem Lett (2015) 25: 292-296 [PMID:25499438]
ChEMBL Displacement of [125I]NT at rat NTS2 overexpressed in CHOK1 cells after 30 mins by gamma counting B 7.72 pKi 18.9 nM Ki J Med Chem (2014) 57: 5318-5332 [PMID:24856674]
ChEMBL Antagonist activity at rat NTS2 receptor expressed in CHO-K1 cells assessed as inhibition of SR142948a-induced calcium mobilization by FLIPR assay F 6.94 pIC50 114 nM IC50 J Med Chem (2014) 57: 7472-7477 [PMID:25157640]
ChEMBL Antagonist activity at rat neurotensin receptor type 2 expressed in CHOK1 cells assessed as inhibition of SR142948a-induced calcium release by FLIPR assay F 7.38 pIC50 42 nM IC50 Bioorg Med Chem Lett (2015) 25: 292-296 [PMID:25499438]
ChEMBL Antagonist activity at rat NTS2 stably expressed in CHOK1 cells assessed as inhibition of SR142948a-induced calcium release by FLIPR assay F 7.73 pIC50 18.5 nM IC50 J Med Chem (2014) 57: 5318-5332 [PMID:24856674]
GtoPdb - - 8.2 pIC50 - - - J Biol Chem (1999) 274: 13752-9 [PMID:10318778]
ChEMBL Agonist activity at rat neurotensin receptor type 2 expressed in CHOK1 cells assessed as increase in calcium release by FLIPR assay F 7 pEC50 >100 nM EC50 Bioorg Med Chem Lett (2015) 25: 292-296 [PMID:25499438]
Neurotensin receptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3091] [UniProtKB: Q99523]
ChEMBL Displacement of [3H]-neurotensin from human sortilin incubated 30 mins prior to [3H]-neurotensin addition measured after 6 hrs by scintillation proximity assay B 6.44 pIC50 360 nM IC50 Bioorg Med Chem Lett (2014) 24: 177-180 [PMID:24355129]

ChEMBL data shown on this page come from version 32:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]